From laser vision correction to adjustable lens implants, the Center for Refractive Solutions at New York Eye and Ear ...

To conduct the study, the investigators obtained data on coffee consumption from genome‐wide association studies (GWAS) and ...

Funding will support continued product development, while the board is composed of “global leaders in posterior and anterior ...

A look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Fluorescence lifetime imaging ophthalmoscopy is emerging as a valuable tool to reveal previously hidden links between retinal ...

The center aims to optimize patients' vision with a range of cataract and corneal refractive procedures and minimize reliance ...

Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...

Effective treatment for Demodex blepharitis includes antibiotics, steroids, and lotilaner ophthalmic solution, which resolves ...

Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.

A study reveals significant retinal vessel changes in diabetic retinopathy, highlighting the need for early detection methods ...